Faricimab Effectively Resolves Intraretinal Fluid and Preserves Vision in Refractory, Recalcitrant, and Nonresponsive Neovascular Age-Related Macular Degeneration-Reference-Cited by-同舟云学术

Faricimab Effectively Resolves Intraretinal Fluid and Preserves Vision in Refractory, Recalcitrant, and Nonresponsive Neovascular Age-Related Macular Degeneration

Published:2023-06-07 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Cheng Anny M,Joshi Sunir,Banoub Raphael G,Saddemi Jackson,Chalam Kakarla V

Publisher

Springer Science and Business Media LLC

Subject

Aerospace Engineering

Reference34 articles.

1. Pathogenesis of disciform detachment of the neuroepithelium;Gass JD;Am J Ophthalmol,1967

3. Emerging vascular endothelial growth factor antagonists to treat neovascular age-related macular degeneration;Hussain RM;Expert Opin Emerg Drugs,2017

4. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results;Martin DF;Ophthalmology,2012

5. Initial non-responders to ranibizumab in the treatment of age-related macular degeneration (AMD);Otsuji T;Clin Ophthalmol,2013

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-acting delivery and therapies for neovascular age-related macular degeneration;Expert Opinion on Biological Therapy;2024-07-22

2. Real-world efficacy of intravitreal faricimab for neovascular age-related macular degeneration: a systematic review;International Journal of Retina and Vitreous;2024-07-12

3. Real-World Outcomes of a Loading Phase with Intravitreal Faricimab in Neovascular Age-Related Macular Degeneration (n-AMD) and Diabetic Macular Edema (DME);Ophthalmology and Therapy;2024-06-04

4. LESS IS MORE;Retina;2024-05

5. One-year visual and anatomical outcomes of intravitreal faricimab injection for neovascular age-related macular degeneration after prior brolucizumab treatment;Scientific Reports;2024-04-20